EU, agreement with Pfizer-Biontech for 1.8 billion doses of vaccine “The European Union is working on a new contract with Pfizer-Biontech for 1.8 billion doses of covid-19 vaccine for the period 2021-2023. “. This was announced by European Commission President Ursula von der Leyen during a press conference with Pfizer’s CEO Albert Bourla at the Puurs plant, along with Belgian Prime Minister De Croo.
At least 26 EU countries have joined the European Commission’s decision to initiate legal lawsuits against AstraZeneca. It was learned from a number of European diplomatic sources. Decisions of the heads of state are communicated through the steering committee mechanism (the committee brings together the Committee and the capitals). Germany was one of the last to agree. However, the sources were unable to confirm that Hungary was fine. However, in principle, the Community Steering Committee should take legal action. A decision in this regard is expected for today.
The European Drug Administration (EMA) has recommended continuing the second dose of AstraZeneca vaccine for 4 to 12 weeks after the first, in accordance with the product information. So, in a note, the EMA.
“The balance between the benefits and risks of the AstraZeneca vaccine remains positive for adults in all age groups.” The EMA said in a note, which notes that “the benefits of vaccination increase as age and infection rates increase”.
The European Drug Administration (EMA) in its new review reiterated that the benefits of the AstraZeneca vaccine outweigh the risks, reiterating that “national authorities are looking at other factors and how to use the best vaccine “.
INTRODUCTION RESERVED © Copyright ANSA